(Q40594630)

21 September 2017

1 reference

title

EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease (English)

1 reference

21 September 2017

McKnight JL

1

1 reference

21 September 2017

Cen H

2

1 reference

21 September 2017

Riddler SA

3

1 reference

21 September 2017

Breinig MC

4

1 reference

21 September 2017

Williams PA

5

1 reference

21 September 2017

Ho M

6

1 reference

21 September 2017

Joseph PS

7

1 reference

21 September 2017

publication date

1 September 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

15

1 reference

21 September 2017

issue

1-2

1 reference

21 September 2017

page(s)

9-16

1 reference

Early events in Epstein-Barr virus infection provide a model for B cell activation

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

A mechanism of T cell regulation of Epstein-Barr virus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Human T cell responses to the Epstein-Barr nuclear antigen-1 (EBNA-1) as evaluated by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Scid mouse model of epstein-barr virus-induced lymphomagenesis of immunodeficient humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409051672

10.3109/10428199409051672

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference